These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39056192)

  • 1. Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases.
    Gellert J; Agardy DA; Kumar S; Kourtesakis A; Boschert T; Jähne K; Breckwoldt MO; Bunse L; Wick W; Davies MA; Platten M; Bunse T
    Cancer Res Commun; 2024 Aug; 4(8):2189-2202. PubMed ID: 39056192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma.
    Shao G; Cui X; Wang Y; Luo S; Li C; Jiang Y; Cai D; Li N; Li X
    CNS Neurosci Ther; 2024 Jul; 30(7):e14791. PubMed ID: 38997808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-linked macropore hydrogel based on M1 macrophage lysate and alginate regulates tumor-associated macrophages for the treatment of melanoma.
    Li W; Ye Q; Jiang Z; Xia D; Yan Z; Wang D; Chen Y; Cao T; Wang J; Lin C; Yang H; Deng J; Lin J
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132089. PubMed ID: 38705331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment.
    Snacel-Fazy E; Soubéran A; Grange M; Joseph K; Colin C; Morando P; Luche H; Pagano A; Brustlein S; Debarbieux F; Toutain S; Siret C; van de Pavert SA; Rougon G; Figarella-Branger D; Ravi VM; Tabouret E; Tchoghandjian A
    Cell Death Dis; 2024 Sep; 15(9):676. PubMed ID: 39278921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
    Li S; Sheng J; Zhang D; Qin H
    Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
    Eisinger S; Sarhan D; Boura VF; Ibarlucea-Benitez I; Tyystjärvi S; Oliynyk G; Arsenian-Henriksson M; Lane D; Wikström SL; Kiessling R; Virgilio T; Gonzalez SF; Kaczynska D; Kanatani S; Daskalaki E; Wheelock CE; Sedimbi S; Chambers BJ; Ravetch JV; Karlsson MCI
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32005-32016. PubMed ID: 33229588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response.
    Tanagala KKK; Morin-Baxter J; Carvajal R; Cheema M; Dubey S; Nakagawa H; Yoon A; Cheng YL; Taylor A; Nickerson J; Mintz A; Momen-Heravi F
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
    Smalley I; Chen Z; Phadke M; Li J; Yu X; Wyatt C; Evernden B; Messina JL; Sarnaik A; Sondak VK; Zhang C; Law V; Tran N; Etame A; Macaulay RJB; Eroglu Z; Forsyth PA; Rodriguez PC; Chen YA; Smalley KSM
    Clin Cancer Res; 2021 Jul; 27(14):4109-4125. PubMed ID: 34035069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer.
    Cruz LS; Robinson M; Stevenson D; Amador IC; Jordan GJ; Valencia S; Navarrete C; House CD
    Cancer Res Commun; 2024 Oct; 4(10):2638-2652. PubMed ID: 39287565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
    Liu H; Yao M; Ren J
    Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F1 fraction isolated from Mesobuthus eupeus scorpion venom induces macrophage polarization toward M1 phenotype and exerts anti-tumoral effects on the CT26 tumor cell line.
    Sadeghi M; Amari A; Asadirad A; Nemati M; Khodadadi A
    Int Immunopharmacol; 2024 May; 132():111960. PubMed ID: 38554440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response.
    Cheng F; He L; Wang J; Lai L; Ma L; Qu K; Yang Z; Wang X; Zhao R; Weng L; Wang L
    Nanoscale; 2024 Oct; 16(39):18570-18583. PubMed ID: 39291343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large, Anionic Liposomes Enable Targeted Intraperitoneal Delivery of a TLR 7/8 Agonist To Repolarize Ovarian Tumors' Microenvironment.
    Kang Y; Flores L; Ngai HW; Cornejo YR; Haber T; McDonald M; Moreira DF; Gonzaga JM; Abidi W; Zhang Y; Hammad M; Kortylewski M; Aboody KS; Berlin JM
    Bioconjug Chem; 2021 Aug; 32(8):1581-1592. PubMed ID: 34289694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.
    Fernando V; Zheng X; Sharma V; Sweef O; Choi ES; Furuta S
    Life Sci Alliance; 2024 Nov; 7(11):. PubMed ID: 39191486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
    ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.